New clinic aims to tackle obesity and heart disease together

NCT ID NCT06053645

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether a cardiometabolic clinic can help obese adults with heart disease lose weight and improve health. Sixty participants will receive care from the clinic and be followed for 12 months. Researchers will measure weight loss, body mass index, and fat distribution, along with blood pressure and diet quality.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
cardiometabolic clinic (multidisciplinary care program)
What this could lead to
If successful, this clinic model could become a standard way to help people with both obesity and heart disease lose weight and lower their heart risks.
What could go wrong
This is a small pilot study with only 60 participants and no comparison group, so results may not apply broadly. Weight loss and health improvements may be modest or not sustained.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADULT CONGENITAL HEART DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Mayo Clinic in Rochester

    RECRUITING

    Rochester, Minnesota, 55905, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.